EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Von Willebrand factor, coagulation factor VIII and ADAMTS-13 in patients with coronary artery disease undergoing endovascular interventions on coronary arteries

Tital S. Broyan, Nina D. Mzhavanadze, Alexander S. Pshennikov, Vladimir A. Ydin, Aleksandr A. Nikiforov

I.P. Pavlov Russian Medical Biological Herald · 30.06.2026 · 34 (2) · 241-248

DOI: 10.17816/pavlovj677821 ↗

Kurz gefasst

Fachartikel in der Zeitschrift I.P. Pavlov Russian Medical Biological Herald, online erschienen am 30.06.2026. Verfasst von Tital S. Broyan und 4 weiteren Autor:innen. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The outcome of percutaneous coronary interventions (PCI) is determined by various factors. One of these factors, which often comes to the forefront, is the state of the system of hemostasis. AIM: To research the levels of von Willebrand factor (vWF), coagulation factor VIII (FVIII) and ADAMTS-13 in patients with acute and chronic coronary artery disease (CAD) and with suspicion of CAD, who underwent coronary angiography and coronary stenting. METHODS: A prospective study included 100 patients with CAD who underwent invasive coronary angiography and coronary stenting for indications. The patients were divided into three groups: group A (n = 37) — patients with stable CAD who underwent percutaneous coronary intervention (PCI) in the form of coronary artery stenting (mean age — 62 (56; 68) years); group B (n = 34) — patients with acute coronary syndrome (ACS) who also underwent PCI (mean age — 64 (54; 69) years); group C (n = 29) — patients with suspicion of CAD, who underwent coronary angiography, which revealed no damage to the coronary arteries (mean age — 65 (56; 70) years). All patients had peripheral venous blood samples taken before the intervention, 24 hours and 1 month after the intervention to assess the levels of vWF, FVIII and ADAMTS-13 metalloproteinase using enzyme immunoassay. RESULTS: In patients of group A, the vWF level was 57.99 (42.45; 81.52) ng/ml, in group B — 57.06 (42.34; 122.95) ng/ml, in group C — 42.28 (31.74; 49.72) ng/ml (p = 0.031). The FVIII level before surgery in group A was 35.70 (26.16; 47.80) ng/ml, in group B — 34.53 (28.21; 48.15) ng/ml, in group C — 25.02 (18.99; 32.91) ng/ml (p = 0.025). No intergroup differences in the ADAMTS-13 parameter were found. In the immediate (24 hours) and late (1 month) periods after endovascular intervention, no statistically significant intragroup changes in the levels of vWF, FVIII and ADAMTS-13 were recorded. CONCLUSION: In patients with acute and chronic CAD with hemodynamically significant coronary atherosclerosis and indications for PCI, baseline vWF and FVIII levels were statistically significantly higher than in patients without lesions of coronary arteries, which reflects a shift in the hemostasis system toward hypercoagulation. Elevated vWF and FVIII levels can be considered markers of severity of atherosclerotic lesion of coronary vessels, but further research is needed to assess their prognostic significance for thrombotic complications after PCI.

Zitieren

APA

Broyan, T. S., Mzhavanadze, N. D., Pshennikov, A. S., Ydin, V. A., & Nikiforov, A. A. (2026). Von Willebrand factor, coagulation factor VIII and ADAMTS-13 in patients with coronary artery disease undergoing endovascular interventions on coronary arteries. I.P. Pavlov Russian Medical Biological Herald, 34(2), 241-248. https://doi.org/10.17816/pavlovj677821

Vancouver

Broyan TS, Mzhavanadze ND, Pshennikov AS, Ydin VA, Nikiforov AA. Von Willebrand factor, coagulation factor VIII and ADAMTS-13 in patients with coronary artery disease undergoing endovascular interventions on coronary arteries. I.P. Pavlov Russian Medical Biological Herald. 2026;34(2):241-248. doi:10.17816/pavlovj677821

BibTeX
@article{Broyan2026,
  author = {Broyan, Tital S. and Mzhavanadze, Nina D. and Pshennikov, Alexander S. and Ydin, Vladimir A. and Nikiforov, Aleksandr A.},
  title = {Von Willebrand factor, coagulation factor VIII and ADAMTS-13 in patients with coronary artery disease undergoing endovascular interventions on coronary arteries},
  journal = {I.P. Pavlov Russian Medical Biological Herald},
  year = {2026},
  volume = {34},
  number = {2},
  pages = {241--248},
  doi = {10.17816/pavlovj677821}
}
Kostenlos starten →